On August 5, American medical media STAT reported that in a pediatric gene editing trial at the Shanghai Children's Medical Center, a young boy died after receiving a high-dose treatment due to a severe immune response and acute respiratory distress syndrome. The incident was only disclosed nearly a year later.
Chronicle entry